Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.
about
Prostacyclin for pulmonary hypertension in adultsMechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle DisordersMedical treatment update on pulmonary arterial hypertensionPulmonary vascular complications of liver diseaseThe clinical significance of antiphospholipid antibodies in systemic lupus erythematosusRecent strategies in treatment of pulmonary arterial hypertension, a reviewInhaled iloprost in pulmonary arterial hypertension.Clinical presentation, differential diagnosis, and vasodilator testing of pulmonary hypertension.Pulmonary hypertension: diagnosis and managementSildenafil for pulmonary hypertension.Right-to-left shunt with hypoxemia in pulmonary hypertension.The right ventricle: biologic insights and response to diseaseIntratracheal gene transfer of adrenomedullin using polyplex nanomicelles attenuates monocrotaline-induced pulmonary hypertension in ratsTimed response to inhaled nitric oxide in pulmonary hypertension.A patient with severe pulmonary hypertension for hip arthroplastySaudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pregnancy in pulmonary hypertensionPulmonary arterial hypertension in France: results from a national registry.Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel reportOral anticoagulants in pediatric cardiac practice: A systematic review of the literature.Portopulmonary hypertension: challenges in diagnosis and management.Integrated care and optimal management of pulmonary arterial hypertensionDiagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guidelineThrombin has biphasic effects on the nitric oxide-cGMP pathway in endothelial cells and contributes to experimental pulmonary hypertension.Non-congenital heart disease associated pediatric pulmonary arterial hypertensionPersonalized genomic medicine: lessons from the exome.Diagnosis and management of pulmonary arterial hypertensionVasoreactivity to inhaled nitric oxide with oxygen predicts long-term survival in pulmonary arterial hypertensionRapid initiation of intravenous epoprostenol infusion is the favored option in patients with advanced pulmonary arterial hypertensionOverview of current therapeutic approaches for pulmonary hypertension.Surgical treatment of pulmonary hypertension: Lung transplantationPulmonary arterial hypertension: advances in pathophysiology and management.Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Transition from intravenous epoprostenol to oral or subcutaneous therapy in pulmonary arterial hypertension: a retrospective case series and systematic reviewStability and microbiological properties of a new formulation of epoprostenol sodium when reconstituted and dilutedEpoprostenol treatment in children with severe pulmonary hypertension.Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil.A review of pulmonary arterial hypertension: role of ambrisentan.Carbon monoxide reverses established pulmonary hypertensionCurrent treatment strategies for pulmonary arterial hypertension.Non-prostanoid prostacyclin agonists for the treatment of pulmonary arterial hypertension.
P2860
Q24246933-8A428029-6146-40B7-A7B1-6D33F1A5EA60Q26753129-93FA3D1E-3E1A-42A5-A22C-ED0348BEDBF7Q26785995-EAF1324E-C8E5-49F8-A4F5-2C72FB1CF5E2Q27021918-63C1AE38-1B28-4A69-9EB0-EAC8751D8DB1Q28072610-5E21080C-01F5-4A40-9221-13140C22A218Q28084702-87D69ED4-655A-4098-9956-CD9550900820Q30437211-7E585FAA-D0BC-4B87-A898-46DA53D1514DQ33155179-BD6C4B38-15D7-4046-86C4-0F97B84ADA65Q33157071-1B5AB2FF-3818-4F6E-8A6F-27E768849CDCQ33213984-E28D252B-BB5D-4E4D-BFEB-3724618B3C36Q33425021-08A210D4-D87A-4F89-B2DE-2D5E52E120DFQ33578032-4C69D0E4-70DE-493D-8AE7-4B6813A31DD1Q33713831-F0937809-CF52-4FD8-B444-0E60D61CA98FQ33805925-AFC8810C-A4FF-444C-93BD-C0E3123DCCBCQ33808583-3741415C-D6CF-43F1-A147-22F5B5764C1FQ33965848-C3585024-16C3-4D97-AF3D-E947EC1EC3D7Q33993302-798C02BA-250A-4D28-B3DF-F004902EDB82Q34064492-1CB995EA-1EF1-48C6-A78C-19BD7D807839Q34065309-9406C80D-A4E7-4735-9A57-98D4C0053E17Q34409046-389592DD-8358-4761-B730-0F0237666596Q34417785-A1392BBE-9EBE-4A4E-B3D9-D2EA61F73B6DQ34425513-4AE6479D-C9DB-4C87-A335-461ACB0FD103Q34778575-C03453C7-7FF3-45D7-A018-C17C49DE87F0Q35165691-1C2DE6FE-0196-40DD-8B22-CD7F4487ED5DQ35209483-80CD9E52-F126-428D-B150-7B8B7A2C6D35Q35222937-5FFDA523-8F8B-4EAF-B174-86D3CEE0CDB5Q35245746-55C35599-4CA8-4DD1-BF47-DFB62AA335E4Q35284774-0BD381B6-ED2B-48C8-BB9E-D266000D35A4Q35412362-7245FB3A-1CA9-4C1D-8531-ACC1FB218AD8Q35573926-0ABF0D3A-D077-49B2-BDDC-FC8C28A67742Q35732584-9248A68D-113B-4368-B534-C76E01AF6FC4Q35752608-D52F4FF5-AB66-485E-AF9B-5A88AF9A8054Q35895629-3DD81DA5-1964-4E13-A78D-80700EAEF3A6Q35922093-DBF8DB71-3812-4BC3-BB71-F807F46193EAQ35954745-A83F3BEF-6B53-435A-9D62-24CFE19DD172Q35987352-7FB9231C-52CC-4215-8C9A-63014C534EC1Q36013161-62FB64D8-FE4F-4216-9194-16CFA390E72EQ36228873-931DC6D6-67EE-4135-9BF3-127CD61D1F7CQ36237720-72CAA57E-59DC-46A0-BA51-5DDE3D17CE4AQ36407328-A7976A5D-50DA-4B9D-931E-7787ADB223B2
P2860
Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Medical therapy for pulmonary ...... clinical practice guidelines.
@en
Medical therapy for pulmonary ...... clinical practice guidelines.
@nl
type
label
Medical therapy for pulmonary ...... clinical practice guidelines.
@en
Medical therapy for pulmonary ...... clinical practice guidelines.
@nl
prefLabel
Medical therapy for pulmonary ...... clinical practice guidelines.
@en
Medical therapy for pulmonary ...... clinical practice guidelines.
@nl
P2093
P1433
P1476
Medical therapy for pulmonary ...... clinical practice guidelines.
@en
P2093
David B Badesch
Douglas C McCrory
Gerald Simonneau
Gregory S Ahearn
Robyn J Barst
Steve H Abman
Vallerie V McLaughlin
P304
P356
10.1378/CHEST.126.1_SUPPL.35S
P407
P433
P577
2004-07-01T00:00:00Z